# EFFECTIVENESS OF ZINC AS AN ADJUVANT TO STANDARD THERAPY VERSUS STANDARD THERAPY ALONE IN CHILDREN

> **NCT06869798** · PHASE3 · COMPLETED · sponsor: **King Edward Medical University** · enrollment: 84 (actual)

## Conditions studied

- Asthma in Children

## Interventions

- **DRUG:** zinc sulphate

## Key facts

- **NCT ID:** NCT06869798
- **Lead sponsor:** King Edward Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-08-28
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06869798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06869798, "EFFECTIVENESS OF ZINC AS AN ADJUVANT TO STANDARD THERAPY VERSUS STANDARD THERAPY ALONE IN CHILDREN". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06869798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*